Cyanotech Corporation Stock

Equities

CYAN

US2324373016

Pharmaceuticals

Market Closed - OTC Markets 01:59:56 2024-04-10 pm EDT 5-day change 1st Jan Change
0.33 USD -4.35% Intraday chart for Cyanotech Corporation -17.50% -62.92%
Sales 2022 35.97M Sales 2023 23.18M Capitalization 5.5M
Net income 2022 2M Net income 2023 -3M EV / Sales 2022 0.75 x
Net Debt 2022 6.02M Net Debt 2023 10.19M EV / Sales 2023 0.68 x
P/E ratio 2022
9.63 x
P/E ratio 2023
-1.59 x
Employees 86
Yield 2022 *
-
Yield 2023
-
Free-Float 67.21%
More Fundamentals * Assessed data
Dynamic Chart
Cyanotech Corporation(NasdaqCM:CYAN) dropped from S&P TMI Index CI
Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index CI
Transcript : Cyanotech Corporation, Q3 2024 Earnings Call, Feb 09, 2024
Earnings Flash (CYAN) CYANOTECH CORPORATION Posts Q3 Revenue $5.6M MT
Cyanotech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Cyanotech Insider Bought Shares Worth $400,000, According to a Recent SEC Filing MT
Cyanotech Corporation announced that it has received $0.4 million in funding from The Michael Arlen Davis Revocable Trust CI
Cyanotech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Cyanotech Corporation Enters into A Second Amendment to the Amended and Restated Promissory Note with Skywords Family Foundation, Inc CI
Transcript : Cyanotech Corporation, Q1 2024 Earnings Call, Aug 14, 2023
Earnings Flash (CYAN) CYANOTECH CORPORATION Posts Q1 Revenue $5.1M MT
Cyanotech Corporation Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer CI
Cyanotech Corporation and Skywords Family Foundation, Inc. Executes Letter of Intent to Commence Drafting and Negotiating A Definitive Second Amendment to the Amended and Restated Promissory Note CI
Earnings Flash (CYAN) CYANOTECH CORPORATION Reports Q4 Revenue $5.4M MT
More news
1 day-4.35%
1 week-17.50%
Current month+13.40%
1 month+13.60%
3 months-64.89%
6 months-58.29%
Current year-62.92%
More quotes
1 week
0.30
Extreme 0.3
0.35
1 month
0.29
Extreme 0.29
0.50
Current year
0.12
Extreme 0.12
0.96
1 year
0.12
Extreme 0.12
1.16
3 years
0.12
Extreme 0.12
3.95
5 years
0.00
Extreme 0
6.29
10 years
0.00
Extreme 0
10.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 14-12-31
Founder 75 82-12-31
Director of Finance/CFO 52 20-09-27
Members of the board TitleAgeSince
Director/Board Member 63 16-05-16
Founder 75 82-12-31
Director/Board Member 47 21-11-07
More insiders
Date Price Change Volume
24-04-10 0.33 -4.35% 38,275
24-04-09 0.345 -13.75% 2,707

Delayed Quote OTC Markets, April 10, 2024 at 01:59 pm EDT

More quotes
Cyanotech Corporation is an agricultural company. It is engaged in the production of natural products derived from microalgae grown in complex and intricate agricultural systems on the Kona coast of Hawaii. It cultivates, on a large-scale basis, two microalgal species from which its two major product lines, natural astaxanthin products and spirulina products, are derived. Its products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye, joint and immune health. BioAstin Hawaiian Astaxanthin has expanding applications as a human dietary supplement and dietary ingredient. Hawaiian Spirulina Pacifica is a nutrient-rich dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Its products are sold as consumer-packaged goods.
More about the company